Bayer to Seek Approval for Menopause Drug Elinzanetant
Successful Third Trial Shows Efficacy in Easing Hot Flashes, Providing Relief Amid Pharmaceutical Setback
Germany’s Bayer said in a statement that a third Phase III trial with its elinzanetant drug candidate provided supporting data on…